Frequency-volume charts and bladder diaries should be used when evaluating women with urinary incontinence. Uroflowmetry and an evaluation of post-void residual (urinary volume) are recommended before any form of surgical treatment. If possible, non-surgical treatments (weight reduction, cessation of smoking and pelvic floor muscle training) should be recommended an attempted before any surgical treatment of stress or mixed urinary incontinence. In the case of over active bladder, conservative measures such as bladder training and drug treatment should always be tried before any invasive treatment (Botox or sacral nerve stimulation/SNS).
Prevalence
Urinary leakage affects a large proportion of the female population. In a epidemiologic study using HUNT-data from North-and South Trøndelag (the Norwegian EPICONT study) 1 in 4 women reported having had some form of involuntary urinary leakage. 2 Of the women reporting urinary incontinence, 50 % had stress urinary incontinence (SUI), 36 % mixed urinary incontinence (MUI) and 11 % urgency urinary incontinence (UUI). Both prevalence and the severity of urinary incontinence was shown to increase with increasing age. 2 
Pathogenesis Stress urinary incontinence (SUI)
The cause is believed to be multifactorial; weakening support structures attaching the anterior vaginal and the urethra to the pelvic wall (including damage to the pubo-urethral ligament and/or the pubocervical fascia) and/or injury to the pudendal nerve innervating the muscles of the pelvic floor and the urethra. 
Urgency urinary incontinence (UUS)
The pathogenesis is unknown, but is suggested to involve an increased amount of afferent signalling from the bladder in combination with reduced capacity in the central nervous system to process the increased nervous output from the bladder. One proposed explanation is that of an involuntary micturition reflex initiated by a relaxation of the urethral sphincter followed by a detrusor contraction. Urgency urinary incontinence might be the result of imbalance in the signalling to the bladder in which the parasympatic nerve output might dominate over the sympatic nervous output in the regulation of the bladder function. The involuntary micturition reflex is for most patients with UUS triggered by increased bladder filling, but can in some instances be triggered by increased abdominal pressure (i.e. coughing, standing up from the supine position) and might therefor easily be misjudged as stress urinary incontinence. The latter has been demonstrated in 5 % of women with mixed urinary incontinence 4 
.
Localised causes in the bladder are urinary tract infections (UTIs), bladdertumors, bladderstones or idiopathic age-related degenerative processes (idiopathic OAB). Causes in the central nervous system: neurologic disease or injury such as spinal cord injury, Parkinson's disease, dementia and cerebrovascular disease. Multiple sclerosis can cause both urgency urinary incontinence and detrusor sphincter dyssynergia.
Mixed urinary incontinence (MUI)
The pathogenesis comprises elements of both stress urinary incontinence and urgency urinary incontinence 16 A full gynaecologic examination including a vaginal ultrasound in order to exclude underlying abdominal or pelvic pathology Urinary dip-stick When the patient history suggests stress urinary incontinence A stress test in the semi-lithotomy position visualises the urethra enabling evaluation of any hypermobility and whether or not the leakage occurs synchronous with coughing. Caution: If the leakage continuous after cessation of coughing (not synchronous) a detrusor contraction must be suspected. A detrusor contraction elicited by coughing occurs in approximately 5 % of women complaining of mixed urinary incontinence. 4 If the stress-test in the semi-lithotomy position is negative it should be repeated in the upright position or with the use of a trampoline. 17 The standardised and reproducible coug-jump pad stress-test recommended before surgery: In the standing position the women coughes three times as forcefully as possible and performes 20 jumping jacks (jumping on the spot, abducting and adducting the legs) with the bladder filled with 300 ml saline. A pad is worn and weighed before and after the test. 17;18 The ability to contract the pelvic floor muscles as well as the contractile force should be evaluated as well as perineal sensitivity and the ano-cutaneous reflex.
Risk factors

Before any surgery
Uroflowmetry with minimum 200 ml voided volume. 19 Post-void residual volume measured by catheter or ultrasound ("bladder scan"). Measurement of post-void urinary residual volume has a low reproducibility and should therefore be repeated. 20 Caution should be exercised before surgery if post-void residuals repeatedly are > 100 ml (Pressure-profile of the urethra) When the patient history suggests urgency urinary incontinence Exclude underlying neurologic disease (perineal sensitivity, ano-cutaneous reflex, uroflowmetry and post-void residuals) Exclude urinary tract infections (urine dip-stick or urine culture) Exclude haematuria If no haematuria or suspicion of neurologic disease, medical treatment for suspected idiopathic overactive bladder (OAB) may be initiated without further investigations In the case of haematuria: Cystoscopy and urography If no response to medical treatment: Cystoscopy and filling cystometry If there is inconsistency between patient history and findings at the standardised filling cystometry, an ambulatory cysto-urethrometry with a leakage detector might be considered.
When patient history suggests mixed urinary incontinence
Evaluate the patient as having both stress-and urgency urinary incontinence, but focus on the dominating component. Caution: Women with overactive bladder might also leak during coughing (detrusor contractions elicited by coughing). This leakage continuous after cessation of coughing. 4 
Treatment
General Equipment for urinary incontinence (i.e. catheters, pads) is covered/reimbursed by the use of "blåresept" §5.1 Weight reductions in overweight women 21 Topical oestrogen treatment if vaginal atrophy 22 
Stress urinary incontinence
Pelvic floor muscle training led by competent physiotherapist 23 A list of physiotherapist that have been trained to treat women with urinary incontinence is found online at www.quintet.no Incontinence pessaries can be used during physical exercise like Contrelle Acitvgard R Retropubic tension-free vaginal tape (TVT) has demonstrated excellent long-term results. 24;25 Obturator slings (TOT, TVT-O) has promising 5-7 years results. 26 However, women with a low-pressure urethra has been shown to benefit more from a retropubic TVT than a TVT-O or TOT procedure. 27 The most common postoperative complications after both TVT and obturator slings are voiding dysfunctions and de novo or worsened symptoms of overactive bladder (OAB). All women should therefore be offered minimum one postoperative follow-up consultation 6 -12 months after surgery to evaluate the subjective and objective result and any potential unwanted effects of the surgery (i.e. voiding difficulties or de novo/worsened OAB). This follow-up evaluation should include the standardised cough-jump pad stress test, uroflowmetry and a post-void residual measurement. Voiding difficulties after incontinence surgery may be transient and can in some instances be handled by teaching the woman intermittent self-catheterisation. If no improvement transecting/cutting the sling should be considered. There is to-day no recommendation/consensus in published literature whether or not there exists an optimal time after surgery for cutting the sling. The sling may be transected/cut in the midline or lateral (uni-or bilateral), but cutting laterally lowers the risk of urethral injury. By cutting the sling the woman runs the risk of having recurrence of her incontinence. It is therefore important to inform the woman of the possibility of recurrence before cutting the sling. As an alternative to intermittent catheterisation the sling might be loosened by taking the woman back to the operating theatre, opening the vaginal wound and pull on the sling. This is easiest performed in the first postoperative days, but has been reported performed up to 3 week after surgery.
De novo or worsened OAB symptoms after sling surgery might be caused by obstruction and therefore transecting/cutting might be indicated in some patients. To which extent this alleviate the symptoms is poorly documented in published literature. Transurethral submucosal injection of Bulkamid is used as treatment in patients that is regarded as having a high risk for complications with sling surgery or in cases where sling surgery has not been successful. 29 However, this treatment has so far proven to be less successful than mid-urethral slings.
Manifest stress urinary incontinence and anterior wall prolapse
If both conditions is symptomatic and in need of surgical treatment, the most used treatment regimen in Scandinavia is a two-step procedure. In a two-step procedure, it is important to do the prolapse surgery first as it has been documented that up to 1/3 of the patients are also cured of their incontinence by the prolapse surgery alone and therefore in no need for further incontinence surgery.
30
Occult urinary incontinence and anterior wall prolapse Occult urinary incontinence (stress urinary incontinence on prolapse reduction) as a predictive test for postoperative stress urinary incontinence (POSUI) after prolapse surgery has too low predictive value/diagnostic accuracy to be of use selecting candidates that might benefit from prophylactic sling surgery at the time of prolapse surgery.
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Urgency urinary incontinence Bladder training 32 Medical treatment 33;34 • Antimuscarinics (tolterodin, fesoterodin, oxybutynin, solifenacin, darifenacin) is recommended taken in the afternoon to minimise dry mouth (most common side effect) leading to the patient discontinuing the treatment. The dry mouth will then occur during sleep and for most patients be tolerable. Other common side effects are constipation, urinary retention, blurred vision, drowsiness and reduced cognitive function in elderly patients.
• Selective β3 adrenoreceptor agonist (mirabegron) seems to be more tolerable with fewer side effects. However, it is still not clear whether its efficacy is equal or superior to the antimuscarinic drugs. Botox injections in the bladder wall 35 Neuromodulation treatment; sacral nerve stimulation (SNS), pudendal nerve stimulation and transcutaneous electrical nerve stimulation -TENS (i.e. tibial nerve stimulation) 36 Bladder augmentation/Enterocystoplasty (urology) Urinary diversion surgery (urology)
Mixed urinary incontinence
Treatment is equal to treatment for stress-and urgency urinary incontinence focusing on the most domination component.
